Study area
Uganda is an east African country with a total land surface of 241,551 km 2 . Its capital city is Kampala and its boundaries are Tanzania and Rwanda in the north, South Sudan in the south, Democratic Republic of Congo in the east and Kenya in the west. Its population is around 34.9 million and the population is projected to reach 46.7 million by 2025 (Uganda Bureau of Statistics 2014). Although Uganda is landlocked, it is in the heart of the Great Lake region, and it is surrounded by Lake Victoria (Figure A1 ) -the world's second largest lake, Lake Edward and Lake Albert. Despite the enormous availability of fresh water resources, access to safe water supply is a major challenge in Uganda. Estimates indicate that only 6% of the population have safely managed drinking water services, which include the use of an improved water source that is accessible on premises, available when needed and free from contamination (WHO/UNICEF 2017). Moreover, an estimated 23% of the population still lack access to improved water sources, as shown in Table A2 . In the urban areas, rapid population growth, urbanization and sprawling human settlements continue to put a strain on efforts to increase access to safe water supply. Hence, only 18% of the urban population have access to safely managed drinking water services. In the rural areas, where the majority (84%) of the population live, the financing required to facilitate safely managed drinking water services (such as piped water) in most cases exceeds the rural districts' budgets (Ministry of Water and Environment 2013). As a result, only 4% of the rural population have access to safely managed drinking water services (WHO/UNICEF 2017). Residents without access to safe water supplies rely on sources such as unprotected springs, swamps, rivers and lakes, which are prone to contamination with enteric pathogens. Others apply household water treatment like boiling, which is both a financial and time burden especially for the women. Moreover, boiled water is mostly cooled in opened containers under ambient conditions making it susceptible to recontamination.
Consequently, enteric diseases, particularly diarrhea morbidity and mortality remain high in Uganda with over 7,000 preschool children dying annually from diarrhea diseases (Table A2 ).
The National Water and Sewerage Corporation (NWSC) is the mandatory body charged with treating and supplying safe drinking water in Uganda. The treatment processes employed include raw water screening, chemical coagulation, flocculation, sedimentation, rapid gravity filtration, chlorination, and pH correction. UV irradiation is sometimes used for disinfection when chlorine is in short supply. Some of the main challenges faced by NWSC include rising treatment costs due to prolific algae blooms in surface water bodies like Lake Victoria (Banadda et al. 2009 ) and chlorine decay caused by leakages in pipes due to cracks and old age, biofilm growth and sludge accumulation in storage tanks, and poor maintenance of distribution systems. Furthermore, there is the need for regular upgrade of the supply system to meet the water demands of the ever-growing population considering that some treatment plants (like the Ggaba I plant installed in 1949) are currently obsolete. 
"Two-points" calculation for UMFI IR and UMFI C : Slope = 0.0000573 and 0.000029, respectively.
(b) Figure A4 . Sensitivity analysis based on the assumption that PACl costs will increase annually, but membrane replacement costs will remain constant; (a), (b), (c), (d), and (e) represent increase in PACl costs at 4%, 8%, 12%, 16%, and 20% per annum, respectively. Even in the scenario where PACl costs increase at 20% per annum (e), PACl dosing at 1.21 mg-Al.L -1 provides cost benefits in the first 3 years. However, for an estimated membrane life of 7 years, PACl dosing will result in a cost penalty of 3 cents/m 3 of treated water. Figure A5 . Sensitivity analysis based on the assumption that membrane replacement costs will diminish annually due to advances in membrane technology, but PACl costs will remain constant; (a), (b), (c), (d), and (e) represent decrease in membrane replacement costs at 4%, 8%, 12%, 16%, and 20% per annum, respectively. Even in the scenario where membrane replacement costs decrease at 20% per annum (e), PACl dosing at 1.21 mg-Al.L -1 provides cost benefits in the first 3 years. However, for an estimated membrane life of 7 years, PACl dosing will result in a cost penalty of <1 cents/m 3 of treated water. Cutback in membrane costs PACl dosing costs still provides cost benefits in the first 2.5 years. However, for an estimated membrane life of 7 years, PACl dosing will result in a cost penalty of 3 cents/m 3 of treated water.
